104 related articles for article (PubMed ID: 23636305)
1. Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin.
Xue TC; Chen RX; Ren ZG; Zou JH; Tang ZY; Ye SL
Oncol Rep; 2013 Jul; 30(1):105-10. PubMed ID: 23636305
[TBL] [Abstract][Full Text] [Related]
2. High expression of CXCR7 combined with Alpha fetoprotein in hepatocellular carcinoma correlates with extra-hepatic metastasis to lung after hepatectomy.
Xue TC; Han D; Chen RX; Zou JH; Wang Y; Tang ZY; Ye SL
Asian Pac J Cancer Prev; 2011; 12(3):657-63. PubMed ID: 21627360
[TBL] [Abstract][Full Text] [Related]
3. CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway.
Xue TC; Jia QA; Bu Y; Chen RX; Cui JF; Tang ZY; Ye SL
Oncol Rep; 2014 Dec; 32(6):2387-96. PubMed ID: 25242412
[TBL] [Abstract][Full Text] [Related]
4. Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.
Xue TC; Zou JH; Chen RX; Cui JF; Tang ZY; Ye SL
Int J Oncol; 2014 Nov; 45(5):1883-90. PubMed ID: 25176314
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.
Lin F; Li Y; Cao J; Fan S; Wen J; Zhu G; Du H; Liang Y
Mol Biol Rep; 2011 Nov; 38(8):5205-10. PubMed ID: 21188534
[TBL] [Abstract][Full Text] [Related]
7. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
[TBL] [Abstract][Full Text] [Related]
8. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
[TBL] [Abstract][Full Text] [Related]
9. CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.
Lin L; Han MM; Wang F; Xu LL; Yu HX; Yang PY
Cell Death Dis; 2014 Oct; 5(10):e1488. PubMed ID: 25341042
[TBL] [Abstract][Full Text] [Related]
10. ShRNA knock-down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Zhao ZW; Fan XX; Song JJ; Xu M; Chen MJ; Tu JF; Wu FZ; Zhang DK; Liu L; Chen L; Ying XH; Ji JS
J Cell Mol Med; 2017 Sep; 21(9):1989-1999. PubMed ID: 28429395
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
[TBL] [Abstract][Full Text] [Related]
12. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.
Monnier J; Boissan M; L'Helgoualc'h A; Lacombe ML; Turlin B; Zucman-Rossi J; Théret N; Piquet-Pellorce C; Samson M
Eur J Cancer; 2012 Jan; 48(1):138-48. PubMed ID: 21778049
[TBL] [Abstract][Full Text] [Related]
13. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
Xin Q; Zhang N; Yu HB; Zhang Q; Cui YF; Zhang CS; Ma Z; Yang Y; Liu W
World J Gastroenterol; 2017 May; 23(17):3053-3065. PubMed ID: 28533662
[TBL] [Abstract][Full Text] [Related]
14. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin.
Dong Q; Zhu X; Dai C; Zhang X; Gao X; Wei J; Sheng Y; Zheng Y; Yu J; Xie L; Qin Y; Qiao P; Zhou C; Yu X; Jia H; Ren N; Zhou H; Ye Q; Qin L
Oncotarget; 2016 Mar; 7(11):12997-3012. PubMed ID: 26824421
[TBL] [Abstract][Full Text] [Related]
16. Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.
Lin F; Huang CM; Cao J; Pei ZH; Gu WL; Fan SF; Li KP; Lin CM
Genet Mol Res; 2015 Nov; 14(4):14440-7. PubMed ID: 26600502
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
18. Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression.
Kang YS; Jeong EJ; Seok HJ; Kim SK; Hwang JS; Choi ML; Jo DG; Kim Y; Choi J; Lee YJ; Jung E; Min JK; Han TS; Kim JS
Biochem Biophys Res Commun; 2019 Jan; 508(1):275-281. PubMed ID: 30497779
[TBL] [Abstract][Full Text] [Related]
19. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.
Liu W; Xu G; Ma J; Jia W; Li J; Chen K; Wang W; Hao C; Wang Y; Wang X
Tohoku J Exp Med; 2011 May; 224(1):29-39. PubMed ID: 21512310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]